🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, claiming the corporations concealed potential risks that the medication presented to pediatric neurological development.

The lawsuit comes four weeks after Former President Trump promoted an unverified association between using acetaminophen - alternatively called paracetamol - while pregnant and autism in children.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever suggested for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he stated they "betrayed America by making money from discomfort and pushing pills without regard for the potential hazards."

Kenvue says there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These companies deceived for years, deliberately risking numerous people to boost earnings," Paxton, a Republican, said.

The company said in a statement that it was "seriously troubled by the spread of false claims on the safety of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its official site, the company also mentioned it had "regularly reviewed the relevant science and there is insufficient valid information that shows a proven link between taking paracetamol and autism."

Associations acting on behalf of physicians and medical practitioners agree.

The American College of Obstetricians and Gynecologists has said acetaminophen - the key substance in acetaminophen - is a restricted selection for women during pregnancy to treat pain and elevated temperature, which can present major wellness concerns if ignored.

"In multiple decades of investigation on the consumption of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the consumption of paracetamol in any stage of gestation leads to neurodevelopmental disorders in children," the organization commented.

The lawsuit references recent announcements from the Trump administration in claiming the drug is potentially dangerous.

Last month, the former president caused concern from health experts when he told women during pregnancy to "resist strongly" not to take acetaminophen when unwell.

Federal regulators then published an announcement that doctors should contemplate reducing the use of Tylenol, while also mentioning that "a proven link" between the drug and autism spectrum disorder in children has not been proven.

Health Secretary Robert F Kennedy Jr, who supervises the Food and Drug Administration, had promised in April to undertake "comprehensive study program" that would determine the origin of autism in a limited time.

But authorities advised that identifying a single cause of autism - believed by scientists to be the result of a intricate combination of genetic and environmental factors - would prove challenging.

Autism is a category of lifelong neurodivergence and disability that influences how persons encounter and relate to the world, and is recognized using medical professional evaluations.

In his legal document, Paxton - a Trump ally who is campaigning for US Senate - alleges the manufacturer and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism.

The case seeks to make the companies "eliminate any commercial messaging" that states acetaminophen is reliable for pregnant women.

The court case mirrors the complaints of a collection of parents of young ones with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in recently.

Judicial authorities threw out the lawsuit, declaring investigations from the plaintiffs' authorities was inconclusive.